NM_000284.4:c.57+2410dupT
Variant names:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000284.4(PDHA1):c.57+2410dupT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00565 in 411,968 control chromosomes in the GnomAD database, including 19 homozygotes. There are 533 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0062 ( 3 hom., 183 hem., cov: 23)
Exomes 𝑓: 0.0055 ( 16 hom. 350 hem. )
Consequence
PDHA1
NM_000284.4 intron
NM_000284.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.286
Genes affected
PDHA1 (HGNC:8806): (pyruvate dehydrogenase E1 subunit alpha 1) The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle. The PDH complex is composed of multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3). The E1 enzyme is a heterotetramer of two alpha and two beta subunits. This gene encodes the E1 alpha 1 subunit containing the E1 active site, and plays a key role in the function of the PDH complex. Mutations in this gene are associated with pyruvate dehydrogenase E1-alpha deficiency and X-linked Leigh syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant X-19346494-A-AT is Benign according to our data. Variant chrX-19346494-A-AT is described in ClinVar as [Likely_benign]. Clinvar id is 445393.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00621 (674/108600) while in subpopulation SAS AF= 0.0419 (107/2555). AF 95% confidence interval is 0.0354. There are 3 homozygotes in gnomad4. There are 183 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDHA1 | NM_000284.4 | c.57+2410dupT | intron_variant | Intron 1 of 10 | ENST00000422285.7 | NP_000275.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00617 AC: 670AN: 108558Hom.: 3 Cov.: 23 AF XY: 0.00567 AC XY: 179AN XY: 31558
GnomAD3 genomes
AF:
AC:
670
AN:
108558
Hom.:
Cov.:
23
AF XY:
AC XY:
179
AN XY:
31558
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00546 AC: 1655AN: 303368Hom.: 16 Cov.: 4 AF XY: 0.00377 AC XY: 350AN XY: 92854
GnomAD4 exome
AF:
AC:
1655
AN:
303368
Hom.:
Cov.:
4
AF XY:
AC XY:
350
AN XY:
92854
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00621 AC: 674AN: 108600Hom.: 3 Cov.: 23 AF XY: 0.00579 AC XY: 183AN XY: 31610
GnomAD4 genome
AF:
AC:
674
AN:
108600
Hom.:
Cov.:
23
AF XY:
AC XY:
183
AN XY:
31610
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jan 22, 2022
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
See Variant Classification Assertion Criteria. -
May 04, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at